Richard Ebil Ottoo

Personal Details

First Name:	Richard
Middle Name:	Ebil
Last Name:	Ottoo
Suffix:
RePEc Short-ID:	pot49
	[This author has chosen not to make the email address public]

Affiliation

Finance and Economics Department
Lubin School of Business
Pace University

New York City, New York (United States)
http://www.pace.edu/lubin/departments-and-research-centers/finance-and-economics-department/
RePEc:edi:fdpacus (more details at EDIRC)

Citations

Many of the citations below have been collected in an experimental project, CitEc, where a more detailed citation analysis can be found. These are citations from works listed in RePEc that could be analyzed mechanically. So far, only a minority of all works could be analyzed. See under "Corrections" how you can help improve the citation analysis.

Articles

1. Richard Ebil Ottoo, 2018. "Valuation of Corporate Innovation and the Pricing of Risk in the Biopharmaceutical Industry: The Case of Gilead," Journal of Applied Corporate Finance, Morgan Stanley, vol. 30(2), pages 92-107, June.

   Cited by:

   1. Kerong Zhang & Wuyi Liu, 2020. "The Current Status, Trend, and Development Strategies of Chinese Biopharmaceutical Industry With a Challenging Perspective," SAGE Open, , vol. 10(1), pages 21582440209, January.

2. Jouahn Nam & Richard E. Ottoo & John H. Thornton Jr., 2003. "The Effect of Managerial Incentives to Bear Risk on Corporate Capital Structure and R&D Investment," The Financial Review, Eastern Finance Association, vol. 38(1), pages 77-101, February.

   Cited by:

   1. Alexandre Di Giacomo & Pascal Alphonse, 2014. "Incitants Financiers Du Dirigeant Et Niveau D'Endettement Optimal," Post-Print hal-01899182, HAL.
   2. Duong, Kiet Tuan & Banti, Chiara & Instefjord, Norvald, 2021. "Managerial conservatism and corporate policies," Journal of Corporate Finance, Elsevier, vol. 68(C).
   3. Caliskan, Deren & Doukas, John A., 2015. "CEO risk preferences and dividend policy decisions," Journal of Corporate Finance, Elsevier, vol. 35(C), pages 18-42.
   4. Z. Jun Lin & Shengqiang Liu & Fangcheng Sun, 2017. "The Impact of Financing Constraints and Agency Costs on Corporate R&D Investment: Evidence from China," International Review of Finance, International Review of Finance Ltd., vol. 17(1), pages 3-42, March.
   5. Hsiang-Lan Chen & Wen-Tsung Hsu & Yen-Sheng Huang, 2010. "Top management team characteristics, R&D investment and capital structure in the IT industry," Small Business Economics, Springer, vol. 35(3), pages 319-333, October.
   6. Leonard Lundstrum, 2009. "Entrenched management, capital structure changes and firm value," Journal of Economics and Finance, Springer;Academy of Economics and Finance, vol. 33(2), pages 161-175, April.
   7. Daniel Beck & Gunther Friedl & Peter Schäfer, 2020. "Executive compensation in Germany," Journal of Business Economics, Springer, vol. 90(5), pages 787-824, June.
   8. Cassell, Cory A. & Huang, Shawn X. & Manuel Sanchez, Juan & Stuart, Michael D., 2012. "Seeking safety: The relation between CEO inside debt holdings and the riskiness of firm investment and financial policies," Journal of Financial Economics, Elsevier, vol. 103(3), pages 588-610.
   9. Andreas Schueler, 2021. "Executive Compensation and Company Valuation," Abacus, Accounting Foundation, University of Sydney, vol. 57(2), pages 297-324, June.
   10. Kim, Young Sang & Nam, Jouahn & Thornton Jr., John H., 2008. "The effect of managerial bonus plans on corporate derivatives usage," Journal of Multinational Financial Management, Elsevier, vol. 18(3), pages 229-243, July.
   11. Hsiang-Lan Chen & Yen-Sheng Huang, 2006. "Employee stock ownership and corporate R&D expenditures: evidence from Taiwan's information-technology industry," Asia Pacific Journal of Management, Springer, vol. 23(3), pages 369-384, September.
   12. ABDEL AZIZ ADAMA & Jules Roger FEUDJO, 2019. "effet famille : une explication du differentiel d’endettements des entreprises familiales et non familiales," Journal of Academic Finance, RED research unit, university of Gabes, Tunisia, vol. 10(1), pages 2-20, June.
   13. Basma Sellami Mezghanni, 2010. "How Ceo Attributes Affect Firm R&D Spending? New Evidence From A Panel Of French Firms," Post-Print hal-00479532, HAL.
   14. Sinclair Davidson & Robert Brooks, 2004. "R&D, Agency Costs and Capital Structure: International Evidence," Econometric Society 2004 Australasian Meetings 59, Econometric Society.
   15. Michael K. Fung, 2006. "R&D, knowledge spillovers and stock volatility," Accounting and Finance, Accounting and Finance Association of Australia and New Zealand, vol. 46(1), pages 107-124, March.
   16. Coles, Jeffrey L. & Daniel, Naveen D. & Naveen, Lalitha, 2006. "Managerial incentives and risk-taking," Journal of Financial Economics, Elsevier, vol. 79(2), pages 431-468, February.
   17. San Martin-Reyna, J.M. & Duran-Encalada, Jorge A., 2012. "The relationship among family business, corporate governance and firm performance: Evidence from the Mexican stock exchange," Journal of Family Business Strategy, Elsevier, vol. 3(2), pages 106-117.
   18. Juan Manuel San Martin-Reyna & Jorge A. Duran-Encalada, 2015. "Effects of Family Ownership, Debt and Board Composition on Mexican Firms Performance," IJFS, MDPI, vol. 3(1), pages 1-19, March.
   19. Nie, George Y., 2024. "The Missing Dimension of Risk: Evidence from Inside Debt Maturity and Acquisition Choices," SocArXiv jd3c2, Center for Open Science.
   20. Timothy King & Jonathan Williams, 2013. "Bank Efficiency and Executive Compensation," Working Papers 13009, Bangor Business School, Prifysgol Bangor University (Cymru / Wales).
   21. Jens Hagendorff & Francesco Vallascas, 2012. "CEO Pay and Risk-taking in Banking: The Roles of Bonus Plans and Deferred Compensation in Curbing Bank Risk-taking," Chapters, in: James R. Barth & Chen Lin & Clas Wihlborg (ed.), Research Handbook on International Banking and Governance, chapter 9, Edward Elgar Publishing.
   22. Francis, Bill & Gupta, Aparna & Hasan, Iftekhar, 2015. "Impact of compensation structure and managerial incentives on bank risk taking," European Journal of Operational Research, Elsevier, vol. 242(2), pages 651-676.
   23. Hagendorff, Jens & Vallascas, Francesco, 2011. "CEO pay incentives and risk-taking: Evidence from bank acquisitions," Journal of Corporate Finance, Elsevier, vol. 17(4), pages 1078-1095, September.
   24. Guillaume Dumas & Alexandre Di Giacomo & Quentin Arnaud, 2021. "Stock-options: an efficient tool to fight R&D managerial short-termism ? [L’attribution de stock-options : un outil efficace de lutte contre le court-termisme managérial en matière de R&D ?]," Post-Print hal-03948379, HAL.
   25. M. Andrew Fields & Phyllis Y. Keys, 2003. "The Emergence of Corporate Governance from Wall St. to Main St.: Outside Directors, Board Diversity, Earnings Management, and Managerial Incentives to Bear Risk," The Financial Review, Eastern Finance Association, vol. 38(1), pages 1-24, February.
   26. Ahmed Hassanein & Jamal Ali Al-Khasawneh & Hany Elzahar, 2022. "R&D expenditure and managerial ownership: evidence from firms of high-vs-low R&D intensity," Journal of Financial Reporting and Accounting, Emerald Group Publishing Limited, vol. 21(3), pages 654-672, January.
   27. Edacherian, Saneesh & Panicker, Vidya Sukumara, 2022. "Do interlocks by different types of directors affect the nature of internationalization strategy of emerging market multinationals?," International Business Review, Elsevier, vol. 31(4).
   28. Nadeem, Muhammad & Zaman, Rashid & Suleman, Tahir & Atawnah, Nader, 2021. "CEO ability, career concerns, firms’ lifecycle and investments in intellectual capital," International Review of Economics & Finance, Elsevier, vol. 75(C), pages 237-251.
   29. Nam, Jouahn & Tang, Charles & Thornton, John Jr. & Wynne, Kevin, 2006. "The effect of agency costs on the value of single-segment and multi-segment firms," Journal of Corporate Finance, Elsevier, vol. 12(4), pages 761-782, September.
   30. David Hillier & Patrick McColgan & Athanasios Tsekeris, 2022. "How did the Sarbanes–Oxley Act affect managerial incentives? Evidence from corporate acquisitions," Review of Quantitative Finance and Accounting, Springer, vol. 58(4), pages 1395-1450, May.
   31. David Gordon, 2014. "Linkages in Capital Structure Theory and Economics," Research in Applied Economics, Macrothink Institute, vol. 6(3), pages 43-55, September.

3. Garner, Jacqueline L. & Nam, Jouahn & Ottoo, Richard E., 2002. "Determinants of corporate growth opportunities of emerging firms," Journal of Economics and Business, Elsevier, vol. 54(1), pages 73-93.

   Cited by:

   1. Jiayi Lyu & Wanxing Jiang, 2023. "Internationalization Pace, Social Network Effect, and Performance among China’s Platform-Based Companies," Sustainability, MDPI, vol. 15(10), pages 1-21, May.
   2. Calleb Oketch & Stephen Muathe, 2022. "What do strategic responses achieve? An analysis of performance of telecommunication firms in Kenya," International Journal of Research in Business and Social Science (2147-4478), Center for the Strategic Studies in Business and Finance, vol. 11(2), pages 104-118, March.
   3. Hernandez-Perdomo, Elvis & Guney, Yilmaz & Rocco, Claudio M., 2019. "A reliability model for assessing corporate governance using machine learning techniques," Reliability Engineering and System Safety, Elsevier, vol. 185(C), pages 220-231.
   4. Hermans, Raine, 2004. "Finance of Small Bio-pharmaceutical Industry in Finland - Descriptive Analysis," Discussion Papers 888, The Research Institute of the Finnish Economy.
   5. Hyytinen, Ari & Pajarinen, Mika, 2002. "Financing of Technology-Intensive Small Business: Some Evidence on the Uniqueness of the ICT Industry," Discussion Papers 813, The Research Institute of the Finnish Economy.
   6. Aigbe Akhigbe & Stephen F. Borde & Ann Marie Whyte, 2003. "Does an Industry Effect Exist for Initial Public Offerings?," The Financial Review, Eastern Finance Association, vol. 38(4), pages 531-551, November.
   7. Bing Guo & Jing Wang & Steven X. Wei, 2018. "R&D spending, strategic position and firm performance," Frontiers of Business Research in China, Springer, vol. 12(1), pages 1-19, December.
   8. Tangwei Teng & Yi Zhang & Yuefang Si & Jiayi Chen & Xianzhong Cao, 2020. "Government support and firm innovation performance in Chinese science and technology parks: The perspective of firm and sub‐park heterogeneity," Growth and Change, Wiley Blackwell, vol. 51(2), pages 749-770, June.
   9. Lin, Shu-Jou & Lee, Ji-Ren, 2011. "Configuring a corporate venturing portfolio to create growth value: Within-portfolio diversity and strategic linkage," Journal of Business Venturing, Elsevier, vol. 26(4), pages 489-503, July.
   10. Collan, Mikael, 2004. "Giga-Investments: Modelling the Valuation of Very Large Industrial Real Investments," MPRA Paper 4328, University Library of Munich, Germany.
   11. Hermans, Raine & Tahvanainen, Antti-Jussi, 2002. "Ownership and Financial Structure of Biotechnology SMEs: Evidence from Finland," Discussion Papers 835, The Research Institute of the Finnish Economy.
   12. Hermans, Raine, . "International Mega-Trends and Growth Prospects of the Finnish Bio-technology Industry - Essays on New Economic Geography, Market Structure of the Pharmaceutical Industry, Sources of Financing, Intelle," ETLA A, The Research Institute of the Finnish Economy, number 40, June.

4. Ottoo, Richard E., 1998. "Valuation of Internal Growth Opportunities: The Case of a Biotechnology Company," The Quarterly Review of Economics and Finance, Elsevier, vol. 38(3, Part 2), pages 615-633.

   Cited by:

   1. Véronique Bastin & Georges Hübner, 2006. "Concentrated Announcements on Clustered Data: An Event Study on Biotechnology Stocks," Financial Management, Financial Management Association, vol. 35(1), Spring.
      • Véronique Bastin & Georges Hübner, 2006. "Concentrated Announcements on Clustered Data: An Event Study on Biotechnology Stocks," Financial Management, Financial Management Association International, vol. 35(1), pages 129-157, March.
   2. Garner, Jacqueline L. & Nam, Jouahn & Ottoo, Richard E., 2002. "Determinants of corporate growth opportunities of emerging firms," Journal of Economics and Business, Elsevier, vol. 54(1), pages 73-93.
   3. Véronique Bastin & Albert Corhay & Georges Hübner & Pierre-Armand Michel, 2002. "Development path and capital structure of belgian biotechnology firms," Working Paper Research 30, National Bank of Belgium.
   4. Philipp N. Baecker, 2007. "Real Options and Intellectual Property," Lecture Notes in Economics and Mathematical Systems, Springer, number 978-3-540-48264-2, October.
   5. Jay Chok & Jifeng Qian, 2013. "Do Executives' Backgrounds Matter to IPO Investors? Evidence from the Life Science Industry," PLOS ONE, Public Library of Science, vol. 8(5), pages 1-13, May.
   6. Philip Joos & Alexei Zhdanov, 2008. "Earnings and Equity Valuation in the Biotech Industry: Theory and Evidence," Financial Management, Financial Management Association International, vol. 37(3), pages 431-460, September.

More information

Research fields, statistics, top rankings, if available.

Statistics

Access and download statistics for all items

Co-authorship network on CollEc

Corrections

All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. For general information on how to correct material on RePEc, see these instructions.

To update listings or check citations waiting for approval, Richard Ebil Ottoo should log into the RePEc Author Service.

To make corrections to the bibliographic information of a particular item, find the technical contact on the abstract page of that item. There, details are also given on how to add or correct references and citations.

To link different versions of the same work, where versions have a different title, use this form. Note that if the versions have a very similar title and are in the author's profile, the links will usually be created automatically.

Please note that most corrections can take a couple of weeks to filter through the various RePEc services.